{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:45:32Z","timestamp":1783035932123,"version":"3.54.6"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01953-6","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T04:23:49Z","timestamp":1764908629000},"page":"459-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ferritinophagy as a Double-Edged Sword in Cancer: Novel Insights into Therapeutic Targeting of Iron-Driven Ferroptosis"],"prefix":"10.1007","volume":"84","author":[{"given":"Omar I","family":"Badr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayrouz A.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basant A.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar M.","family":"Abdulfatah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed N.","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameis M","family":"Sleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"4","key":"1953_CR1","first-page":"1143","volume":"54","author":"Y. Chen","year":"2019","unstructured":"Chen, Y. (2019). Iron metabolism and its contribution to cancer. International Journal Of Oncology, 54(4), 1143\u20131154.","journal-title":"International Journal Of Oncology"},{"key":"1953_CR2","doi-asserted-by":"publisher","first-page":"115874","DOI":"10.1016\/j.bcp.2023.115874","volume":"218","author":"R. Wang","year":"2023","unstructured":"Wang, R. (2023). Ferritinophagy-mediated apoptosis and paraptosis induction involved MAPK and PI3K\/AKT pathway in mechanism of an iron chelator. Biochemical Pharmacology, 218, 115874.","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"1953_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R. Rodriguez","year":"2022","unstructured":"Rodriguez, R., & Schreiber, S. L. (2022). and M.J.M.c. Conrad, persister cancer cells: Iron addiction and vulnerability to ferroptosis. Molecular Cell, 82(4), 728\u2013740.","journal-title":"Molecular Cell"},{"issue":"43","key":"1953_CR4","doi-asserted-by":"publisher","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","volume":"2","author":"Z. K. Pinnix","year":"2010","unstructured":"Pinnix, Z. K. (2010). Ferroportin and iron regulation in breast cancer progression and prognosis. Science Translational Medicine, 2(43), 43ra56\u201343ra56.","journal-title":"Science Translational Medicine"},{"issue":"11","key":"1953_CR5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-14-2465","volume":"75","author":"L. Tesfay","year":"2015","unstructured":"Tesfay, L. (2015). Hepcidin regulation in prostate and its disruption in prostate cancer. Cancer Research, 75(11), 2254\u20132263.","journal-title":"Cancer Research"},{"issue":"29","key":"1953_CR6","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/onc.2017.11","volume":"36","author":"D. Basuli","year":"2017","unstructured":"Basuli, D. (2017). Iron addiction: A novel therapeutic target in ovarian cancer. Oncogene, 36(29), 4089\u20134099.","journal-title":"Oncogene"},{"issue":"1","key":"1953_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"S. V. Torti","year":"2018","unstructured":"Torti, S. V. (2018). Iron and cancer. Annual Review Of Nutrition, 38(1), 97\u2013125.","journal-title":"Annual Review Of Nutrition"},{"issue":"1","key":"1953_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s42003-024-06704-6","volume":"7","author":"H. Lin","year":"2024","unstructured":"Lin, H. (2024). FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells. Commun Biol, 7(1), 1011.","journal-title":"Commun Biol"},{"key":"1953_CR9","doi-asserted-by":"publisher","first-page":"1032364","DOI":"10.3389\/fonc.2023.1032364","volume":"13","author":"L. Yuan","year":"2023","unstructured":"Yuan, L. (2023). Upregulation of the ferroptosis-related STEAP3 gene is a specific predictor of poor triple-negative breast cancer patient outcomes. Frontiers in Oncology, 13, 1032364.","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"1953_CR10","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1158\/2159-8290.CD-22-0043","volume":"12","author":"N. Santana-Codina","year":"2022","unstructured":"Santana-Codina, N. (2022). NCOA4-mediated ferritinophagy is a pancreatic cancer dependency via maintenance of iron bioavailability for iron\u2013sulfur cluster proteins. Cancer Discovery, 12(9), 2180\u20132197.","journal-title":"Cancer Discovery"},{"issue":"1","key":"1953_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","volume":"24","author":"L. Rochette","year":"2022","unstructured":"Rochette, L. (2022). Lipid peroxidation and iron metabolism: Two corner stones in the homeostasis control of ferroptosis. International Journal Of Molecular Sciences, 24(1), 449.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"7","key":"1953_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/metabo12070609","volume":"12","author":"N. K. Kotla","year":"2022","unstructured":"Kotla, N. K. (2022). The role of ferritin in health and disease: Recent advances and Understandings. Metabolites, 12(7), 609.","journal-title":"Metabolites"},{"key":"1953_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3389\/fnins.2019.01195","volume":"13","author":"B. B. Muhoberac","year":"2019","unstructured":"Muhoberac, B. B., & Vidal, R. (2019). Iron, ferritin, hereditary ferritinopathy, and neurodegeneration. Front Neurosci, 13, 1195.","journal-title":"Front Neurosci"},{"issue":"6","key":"1953_CR14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B. Wang","year":"2023","unstructured":"Wang, B. (2023). ROS-induced lipid peroxidation modulates cell death outcome: Mechanisms behind apoptosis, autophagy, and ferroptosis. Archives Of Toxicology, 97(6), 1439\u20131451.","journal-title":"Archives Of Toxicology"},{"key":"1953_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fnins.2019.00238","volume":"13","author":"M. del Quiles","year":"2019","unstructured":"del Quiles, M., & Mancias, J. D. (2019). NCOA4-mediated ferritinophagy: A potential link to neurodegeneration. Front Neurosci, 13, 238.","journal-title":"Front Neurosci"},{"issue":"1","key":"1953_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"H. Yan","year":"2021","unstructured":"Yan, H. (2021). Ferroptosis: Mechanisms and links with diseases. Signal Transduct Target Ther, 6(1), 49.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1953_CR17","doi-asserted-by":"publisher","first-page":"2564593","DOI":"10.1080\/13510002.2025.2564593","volume":"30","author":"Y. Wu","year":"2025","unstructured":"Wu, Y. (2025). Recent advances in the investigation of the regulatory network underlying reactive nitrogen species-mediated tumorigenesis: Molecular mechanisms and targeted therapeutic strategies. Redox Report, 30(1), 2564593.","journal-title":"Redox Report"},{"issue":"1","key":"1953_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41420-025-02415-x","volume":"11","author":"Y. Liang","year":"2025","unstructured":"Liang, Y. (2025). Ferroptosis: CD8\u2009+\u2009T cells\u2019 blade to destroy tumor cells or poison for self-destruction. Cell Death Discovery, 11(1), 128.","journal-title":"Cell Death Discovery"},{"issue":"2","key":"1953_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12013-024-01248-2","volume":"82","author":"B. E. Ekundayo","year":"2024","unstructured":"Ekundayo, B. E. (2024). Oxidative stress, Endoplasmic reticulum stress and apoptosis in the pathology of alzheimer\u2019s disease. Cell biochemistry and biophysics, 82(2), 457\u2013477.","journal-title":"Cell biochemistry and biophysics"},{"issue":"2\u20133","key":"1953_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","volume":"34","author":"D. Fotiadis","year":"2013","unstructured":"Fotiadis, D., Kanai, Y., & Palac\u00edn, M. (2013). The SLC3 and SLC7 families of amino acid transporters. Molecular Aspects Of Medicine, 34(2\u20133), 139\u2013158.","journal-title":"Molecular Aspects Of Medicine"},{"key":"1953_CR21","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","volume":"9","author":"X. Sui","year":"2018","unstructured":"Sui, X. (2018). RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Frontiers in Pharmacology, 9, 1371.","journal-title":"Frontiers in Pharmacology"},{"key":"1953_CR22","doi-asserted-by":"publisher","first-page":"1188365","DOI":"10.3389\/fimmu.2023.1188365","volume":"14","author":"D. Qi","year":"2023","unstructured":"Qi, D., & Peng, M. (2023). Ferroptosis-mediated immune responses in cancer. Frontiers In Immunology , 14, 1188365.","journal-title":"Frontiers In Immunology"},{"key":"1953_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07726-z","volume":"21","author":"Y. Mou","year":"2021","unstructured":"Mou, Y. (2021). Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma. Bmc Cancer, 21, 1\u201312.","journal-title":"Bmc Cancer"},{"issue":"1","key":"1953_CR24","doi-asserted-by":"publisher","first-page":"2532954","DOI":"10.1080\/21645515.2025.2532954","volume":"21","author":"Y. Wu","year":"2025","unstructured":"Wu, Y. (2025). A systematic review of the latest progress of drug resistance and clinical application of immunotherapy in renal cell carcinoma in the past five years based on bibliometrics. Hum Vaccin Immunother, 21(1), 2532954.","journal-title":"Hum Vaccin Immunother"},{"key":"1953_CR25","doi-asserted-by":"publisher","first-page":"115404","DOI":"10.1016\/j.intimp.2025.115404","volume":"164","author":"H. Lin","year":"2025","unstructured":"Lin, H. (2025). Deciphering the metabolic-epigenetic-immune crosstalk in epstein-barr virus-positive nasopharyngeal carcinoma: Mechanisms and novel therapeutic frontiers. International Immunopharmacology, 164, 115404.","journal-title":"International Immunopharmacology"},{"key":"1953_CR26","doi-asserted-by":"publisher","first-page":"933732","DOI":"10.3389\/fphar.2022.933732","volume":"13","author":"M. Z. Liu","year":"2022","unstructured":"Liu, M. Z. (2022). The critical role of ferritinophagy in human disease. Frontiers In Pharmacology, 13, 933732.","journal-title":"Frontiers In Pharmacology"},{"issue":"7","key":"1953_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","volume":"23","author":"H. Sies","year":"2022","unstructured":"Sies, H. (2022). Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nature Reviews Molecular Cell Biology, 23(7), 499\u2013515.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"3","key":"1953_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14348\/molcells.2023.0005","volume":"46","author":"A. Shakya","year":"2023","unstructured":"Shakya, A. (2023). Anti-ferroptotic effects of Nrf2: Beyond the antioxidant response. Molecules And Cells, 46(3), 165\u2013175.","journal-title":"Molecules And Cells"},{"issue":"9","key":"1953_CR29","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms22094642","volume":"22","author":"C. Andr\u00e9s Juan","year":"2021","unstructured":"Andr\u00e9s Juan, C. (2021). The chemistry of reactive oxygen species (ROS) revisited: Outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. International journal of molecular sciences. 22(9), 4642.","journal-title":"International journal of molecular sciences"},{"issue":"10","key":"1953_CR30","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H. Nakamura","year":"2021","unstructured":"Nakamura, H., & Takada, K. (2021). Reactive oxygen species in cancer: Current findings and future directions. Cancer Science, 112(10), 3945\u20133952.","journal-title":"Cancer Science"},{"issue":"5","key":"1953_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/cells13050441","volume":"13","author":"K. Li","year":"2024","unstructured":"Li, K. (2024). The role of oxidative stress in tumorigenesis and progression. Cells, 13(5), 441.","journal-title":"Cells"},{"key":"1953_CR32","doi-asserted-by":"publisher","first-page":"116324","DOI":"10.1016\/j.biopha.2024.116324","volume":"173","author":"Z. Gong","year":"2024","unstructured":"Gong, Z. (2024). Targeting Nrf2 to treat thyroid cancer. Biomedicine & Pharmacotherapy, 173, 116324.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"1953_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"J. D. Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. (2020). Oxidative stress in cancer. Cancer Cell, 38(2), 167\u2013197.","journal-title":"Cancer Cell"},{"issue":"5","key":"1953_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"E. C. Cheung","year":"2022","unstructured":"Cheung, E. C., & Vousden, K. H. (2022). The role of ROS in tumour development and progression. Nature Reviews Cancer, 22(5), 280\u2013297.","journal-title":"Nature Reviews Cancer"},{"issue":"10","key":"1953_CR35","doi-asserted-by":"publisher","first-page":"e2337494","DOI":"10.1001\/jamanetworkopen.2023.37494","volume":"6","author":"R. T. Bryan","year":"2023","unstructured":"Bryan, R. T. (2023). Selenium and vitamin E for prevention of non\u2013muscle-invasive bladder cancer recurrence and progression: A randomized clinical trial. JAMA network open, 6(10), e2337494\u2013e2337494.","journal-title":"JAMA network open"},{"issue":"4","key":"1953_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.15430\/JCP.24.021","volume":"29","author":"T. Bae","year":"2024","unstructured":"Bae, T., & Kwak, M. K. (2024). Kelch-like ECH-associated protein 1\/Nuclear factor erythroid 2-related factor 2 pathway and its interplay with oncogenes in lung tumorigenesis. J Cancer Prev, 29(4), 89.","journal-title":"J Cancer Prev"},{"issue":"7","key":"1953_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.31083\/j.fbl2807143","volume":"28","author":"G. Tossetta","year":"2023","unstructured":"Tossetta, G. (2023). Cellular modulators of the NRF2\/KEAP1 signaling pathway in prostate cancer. Front Biosci (Landmark Ed), 28(7), 143.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"1953_CR38","doi-asserted-by":"publisher","first-page":"eade9585","DOI":"10.1126\/sciadv.ade9585","volume":"9","author":"A. Anandhan","year":"2023","unstructured":"Anandhan, A. (2023). NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Science Advances, 9(5), eade9585.","journal-title":"Science Advances"},{"issue":"7","key":"1953_CR39","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/antiox10071030","volume":"10","author":"T. Jenkins","year":"2021","unstructured":"Jenkins, T., & Gouge, J. J. A. (2021). Nrf2 in cancer, detoxifying enzymes and cell death programs. Antioxidants (Basel), 10(7), 1030.","journal-title":"Antioxidants (Basel)"},{"issue":"7","key":"1953_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3390\/antiox13070791","volume":"13","author":"D. Liu","year":"2024","unstructured":"Liu, D. (2024). Redox-regulated iron metabolism and ferroptosis in ovarian cancer: Molecular insights and therapeutic opportunities. Antioxidants (Basel), 13(7), 791.","journal-title":"Antioxidants (Basel)"},{"key":"1953_CR41","volume-title":"The intricacies of NRF2 regulation in cancer. Seminars in cancer biology","author":"C. J. Schmidlin","year":"2021","unstructured":"Schmidlin, C. J. (2021). The intricacies of NRF2 regulation in cancer. Seminars in cancer biology. Elsevier."},{"issue":"4","key":"1953_CR42","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A. Anandhan","year":"2020","unstructured":"Anandhan, A. (2020). Breakdown of an ironclad defense system: The critical role of NRF2 in mediating ferroptosis. Cell Chem Biol, 27(4), 436\u2013447.","journal-title":"Cell Chem Biol"},{"issue":"20","key":"1953_CR43","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.1039\/D1FO01036K","volume":"12","author":"J. Lu","year":"2021","unstructured":"Lu, J. (2021). Toward improved human health: Nrf2 plays a critical role in regulating ferroptosis. Food & Function, 12(20), 9583\u20139606.","journal-title":"Food & Function"},{"key":"1953_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2020.00267","volume":"14","author":"X. Song","year":"2020","unstructured":"Song, X. (2020). and D.J.F.i.n. Long, Nrf2 and ferroptosis: A new research direction for neurodegenerative diseases. Front Neurosci, 14, 267.","journal-title":"Front Neurosci"},{"key":"1953_CR45","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1039\/D4CS00404C","volume":"53","author":"X. Jia","year":"2024","unstructured":"Jia, X. (2024). Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy. Chemical Society Reviews, 53, 11590\u201311656.","journal-title":"Chemical Society Reviews"},{"issue":"17","key":"1953_CR46","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"M. J. Kerins","year":"2018","unstructured":"Kerins, M. J., & Ooi, A. J. A. (2018). r. signaling, the roles of NRF2 in modulating cellular iron homeostasis. Antioxidants & Redox Signaling, 29(17), 1756\u20131773.","journal-title":"Antioxidants & Redox Signaling"},{"key":"1953_CR47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/JHC.S395617","volume":"10","author":"Z. Xiu","year":"2023","unstructured":"Xiu, Z. (2023). Inhibitory effects of Esculetin on liver cancer through triggering NCOA4 pathway-mediation ferritinophagy in vivo and in vitro. Journal of Hepatocellular Carcinoma, 10, 611\u2013629.","journal-title":"Journal of Hepatocellular Carcinoma"},{"key":"1953_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-030-62026-4_4","volume":"1301","author":"N. Santana-Codina","year":"2021","unstructured":"Santana-Codina, N. (2021). The role of NCOA4-mediated ferritinophagy in ferroptosis. Advances In Experimental Medicine And Biology, 1301, 41\u201357.","journal-title":"Advances In Experimental Medicine And Biology"},{"issue":"10","key":"1953_CR49","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3390\/antiox11101926","volume":"11","author":"C. A Guggisberg","year":"2022","unstructured":"A Guggisberg, C. (2022). NCOA4 regulates iron recycling and responds to hepcidin activity and lipopolysaccharide in macrophages. Antioxidants (Basel), 11(10), 1926.","journal-title":"Antioxidants (Basel)"},{"key":"1953_CR50","doi-asserted-by":"publisher","first-page":"8865791","DOI":"10.1155\/2021\/8865791","volume":"2021(1)","author":"L. Shen","year":"2021","unstructured":"Shen, L. (2021). Crosstalk between macrophages, T cells, and iron metabolism in tumor microenvironment. Oxidative Medicine and Cellular Longevity, 2021(1), 8865791.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1953_CR51","doi-asserted-by":"publisher","first-page":"110629","DOI":"10.1016\/j.intimp.2023.110629","volume":"122","author":"P. Chen","year":"2023","unstructured":"Chen, P. (2023). ACSL4 promotes ferroptosis and M1 macrophage polarization to regulate the tumorigenesis of nasopharyngeal carcinoma. International Immunopharmacology, 122, 110629.","journal-title":"International Immunopharmacology"},{"key":"1953_CR52","doi-asserted-by":"publisher","first-page":"122386","DOI":"10.1016\/j.biomaterials.2023.122386","volume":"303","author":"M. Chen","year":"2023","unstructured":"Chen, M. (2023). Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy. Biomaterials, 303, 122386.","journal-title":"Biomaterials"},{"key":"1953_CR53","doi-asserted-by":"publisher","first-page":"110051","DOI":"10.1016\/j.abb.2024.110051","volume":"758","author":"X. Zuo","year":"2024","unstructured":"Zuo, X. (2024). Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and Inhibition of M2 macrophage polarization via the MAPK signaling. Archives of Biochemistry and Biophysics, 758, 110051.","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"16","key":"1953_CR54","doi-asserted-by":"publisher","first-page":"8470","DOI":"10.3390\/ijms22168470","volume":"22","author":"H. Wang","year":"2021","unstructured":"Wang, H., Tian, T., & Zhang, J. (2021). Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): From mechanism to therapy and prognosis. International Journal Of Molecular Sciences, 22(16), 8470.","journal-title":"International Journal Of Molecular Sciences"},{"key":"1953_CR55","doi-asserted-by":"publisher","first-page":"727762","DOI":"10.3389\/fcell.2021.727762","volume":"9","author":"Z. W. Hu","year":"2021","unstructured":"Hu, Z. W. (2021). Ferroptosis driver SOCS1 and suppressor FTH1 independently correlate with M1 and M2 macrophage infiltration in head and neck squamous cell carcinoma. Front Cell Dev Biol, 9, 727762.","journal-title":"Front Cell Dev Biol"},{"issue":"21","key":"1953_CR56","doi-asserted-by":"publisher","first-page":"2308208","DOI":"10.1002\/advs.202308208","volume":"11","author":"G. Li","year":"2024","unstructured":"Li, G. (2024). Targeting the MCP-GPX4\/HMGB1 axis for effectively triggering Immunogenic ferroptosis in pancreatic ductal adenocarcinoma. Adv Sci (Weinh), 11(21), 2308208.","journal-title":"Adv Sci (Weinh)"},{"key":"1953_CR57","doi-asserted-by":"publisher","first-page":"1255443","DOI":"10.3389\/fimmu.2023.1255443","volume":"14","author":"Z. Lin","year":"2024","unstructured":"Lin, Z., Zou, S., & Wen, K. J. F. I. (2024). The crosstalk of CD8\u2009+\u2009T cells and ferroptosis in cancer. Frontiers In Immunology , 14, 1255443.","journal-title":"Frontiers In Immunology"},{"issue":"2","key":"1953_CR58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","volume":"110","author":"R. Kong","year":"2021","unstructured":"Kong, R. (2021). IFN\u03b3-mediated repression of system xc\u2009\u2013\u2009drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. Journal of Leukocyte Biology, 110(2), 301\u2013314.","journal-title":"Journal of Leukocyte Biology"},{"key":"1953_CR59","first-page":"4654302","volume":"2021(1)","author":"X. Chen","year":"2021","unstructured":"Chen, X. (2021). Identification of a Ferroptosis-Related signature associated with prognosis and immune infiltration in adrenocortical carcinoma. Int J Endocrinol, 2021(1), 4654302.","journal-title":"Int J Endocrinol"},{"issue":"7","key":"1953_CR60","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S. Xu","year":"2021","unstructured":"Xu, S. (2021). Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8\u2009+\u2009T cells in tumors. Immunity, 54(7), 1561\u20131577e7.","journal-title":"Immunity"},{"issue":"3","key":"1953_CR61","doi-asserted-by":"publisher","first-page":"e70253","DOI":"10.1002\/ctm2.70253","volume":"15","author":"X. Xia","year":"2025","unstructured":"Xia, X. (2025). Ferroptosis of T cell in inflammation and tumour immunity. Clin Transl Med, 15(3), e70253.","journal-title":"Clin Transl Med"},{"issue":"11","key":"1953_CR62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41419-022-05384-6","volume":"13","author":"Q. Dang","year":"2022","unstructured":"Dang, Q. (2022). Ferroptosis: A double-edged sword mediating immune tolerance of cancer. Cell Death And Disease, 13(11), 925.","journal-title":"Cell Death And Disease"},{"issue":"9","key":"1953_CR63","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s10495-024-01973-2","volume":"29","author":"Z. Shen","year":"2024","unstructured":"Shen, Z. (2024). Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-\u03bab pathway inactivation. Apoptosis, 29(9), 1810\u20131823.","journal-title":"Apoptosis"},{"issue":"1","key":"1953_CR64","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1186\/s12885-022-10302-2","volume":"22","author":"Q. Gong","year":"2022","unstructured":"Gong, Q. (2022). CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma. Bmc Cancer, 22(1), 1184.","journal-title":"Bmc Cancer"},{"key":"1953_CR65","doi-asserted-by":"publisher","first-page":"1053137","DOI":"10.3389\/fphar.2022.1053137","volume":"13","author":"Z. Luo","year":"2022","unstructured":"Luo, Z. (2022). Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer. Frontiers in Pharmacology, 13, 1053137.","journal-title":"Frontiers in Pharmacology"},{"key":"1953_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2021.12.011","volume":"527","author":"M. Li","year":"2022","unstructured":"Li, M. (2022). Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma. Cancer Letters, 527, 28\u201340.","journal-title":"Cancer Letters"},{"issue":"1","key":"1953_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","volume":"25","author":"Y. Dai","year":"2025","unstructured":"Dai, Y. (2025). JAK\/STAT signaling as a key regulator of ferroptosis: Mechanisms and therapeutic potentials in cancer and diseases. Cancer Cell International, 25(1), 83.","journal-title":"Cancer Cell International"},{"key":"1953_CR68","doi-asserted-by":"publisher","first-page":"1226443","DOI":"10.3389\/fimmu.2023.1226443","volume":"14","author":"J. Huang","year":"2023","unstructured":"Huang, J. (2023). Function of reactive oxygen species in myeloid-derived suppressor cells. Frontiers In Immunology , 14, 1226443.","journal-title":"Frontiers In Immunology"},{"issue":"6","key":"1953_CR69","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.7150\/thno.105276","volume":"15","author":"H. Wang","year":"2025","unstructured":"Wang, H. (2025). Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: Targets and therapeutic strategies. Theranostics, 15(6), 2159.","journal-title":"Theranostics"},{"issue":"21","key":"1953_CR70","doi-asserted-by":"publisher","first-page":"8387","DOI":"10.3390\/ijms21218387","volume":"21","author":"J. Liu","year":"2020","unstructured":"Liu, J. (2020). The regulation of ferroptosis by tumor suppressor p53 and its pathway. International Journal Of Molecular Sciences, 21(21), 8387.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"11","key":"1953_CR71","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1007\/s10495-024-01997-8","volume":"29","author":"Y. Lu","year":"2024","unstructured":"Lu, Y., Xie, X., & Luo, L. J. A. (2024). Ferroptosis crosstalk in anti-tumor immunotherapy: Molecular mechanisms, tumor microenvironment, application prospects. Apoptosis, 29(11), 1914\u20131943.","journal-title":"Apoptosis"},{"issue":"6","key":"1953_CR72","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4049\/jimmunol.2000500","volume":"206","author":"H. Zhu","year":"2021","unstructured":"Zhu, H. (2021). Asah2 represses the p53\u2013Hmox1 axis to protect myeloid-derived suppressor cells from ferroptosis. The Journal of Immunology, 206(6), 1395\u20131404.","journal-title":"The Journal of Immunology"},{"issue":"5","key":"1953_CR73","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.celrep.2013.04.012","volume":"3","author":"L. J. Valente","year":"2013","unstructured":"Valente, L. J. (2013). p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Cell Rep, 3(5), 1339\u20131345.","journal-title":"Cell Rep"},{"key":"1953_CR74","doi-asserted-by":"publisher","first-page":"818453","DOI":"10.3389\/fcell.2022.818453","volume":"10","author":"J. Deng","year":"2022","unstructured":"Deng, J. (2022). Targeting cancer cell ferroptosis to reverse immune checkpoint inhibitor therapy resistance. Front Cell Dev Biol, 10, 818453.","journal-title":"Front Cell Dev Biol"},{"issue":"15","key":"1953_CR75","doi-asserted-by":"publisher","first-page":"2204514","DOI":"10.1002\/advs.202204514","volume":"10","author":"C. H. Chung","year":"2023","unstructured":"Chung, C. H. (2023). Ferroptosis signature shapes the immune profiles to enhance the response to immune checkpoint inhibitors in head and neck cancer. Adv Sci (Weinh), 10(15), 2204514.","journal-title":"Adv Sci (Weinh)"},{"key":"1953_CR76","unstructured":"Wang, Y. (2025). Interplay of cGAS-STING and ferroptosis: crosstalk, molecular mechanisms, and therapeutic prospects. Archives of toxicology, 1\u201323."},{"issue":"1","key":"1953_CR77","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13046-025-03520-6","volume":"44","author":"C. Li","year":"2025","unstructured":"Li, C. (2025). Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer. Journal Of Experimental & Clinical Cancer Research : Cr, 44(1), 249.","journal-title":"Journal Of Experimental & Clinical Cancer Research : Cr"},{"issue":"11","key":"1953_CR78","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/biom15111546","volume":"15","author":"Y. Cai","year":"2025","unstructured":"Cai, Y., Zhao, F., & Cheng, X. J. B. (2025). Gut microbiota and ferroptosis in colorectal cancer: A comprehensive review of mechanisms and therapeutic strategies to overcome immune checkpoint resistance. Biomolecules, 15(11), 1546.","journal-title":"Biomolecules"},{"key":"1953_CR79","doi-asserted-by":"publisher","first-page":"101160","DOI":"10.1016\/j.drup.2024.101160","volume":"77","author":"Z. Yuan","year":"2024","unstructured":"Yuan, Z. (2024). Targeting NQO1 induces ferroptosis and triggers anti-tumor immunity in immunotherapy-resistant KEAP1-deficient cancers. Drug Resistance Updates : Reviews And Commentaries In Antimicrobial And Anticancer Chemotherapy, 77, 101160.","journal-title":"Drug Resistance Updates : Reviews And Commentaries In Antimicrobial And Anticancer Chemotherapy"},{"key":"1953_CR80","doi-asserted-by":"publisher","first-page":"1558290","DOI":"10.3389\/fonc.2025.1558290","volume":"15","author":"C. Wang","year":"2025","unstructured":"Wang, C. (2025). Synergistic effects of 5-fluorouracil in combination with salinomycin promoted ferroptosis via inhibiting SLC7A11\/GPX4 in colorectal cancer. Frontiers In Oncology, 15, 1558290.","journal-title":"Frontiers In Oncology"},{"issue":"5","key":"1953_CR81","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/cells12050733","volume":"12","author":"A. Jehl","year":"2023","unstructured":"Jehl, A. (2023). Blocking EREG\/GPX4 sensitizes head and neck cancer to cetuximab through ferroptosis induction. Cells, 12(5), 733.","journal-title":"Cells"},{"issue":"7","key":"1953_CR82","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/tox.23509","volume":"37","author":"S. Wang","year":"2022","unstructured":"Wang, S. (2022). A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis. Environmental Toxicology, 37(7), 1597\u20131607.","journal-title":"Environmental Toxicology"},{"issue":"5","key":"1953_CR83","first-page":"307","volume":"13","author":"A. Mitra","year":"2024","unstructured":"Mitra, A. (2024). Current landscape of cancer immunotherapy: Harnessing the immune arsenal to overcome immune evasion. Biology (Basel), 13(5), 307.","journal-title":"Biology (Basel)"},{"issue":"12","key":"1953_CR84","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/2326-6066.CIR-24-0130","volume":"12","author":"Y. Gao","year":"2024","unstructured":"Gao, Y. (2024). CAR T cells engineered to secrete IFN\u03ba induce tumor ferroptosis via an IFNAR\/STAT1\/ACSL4 axis. Cancer immunology research, 12(12), 1691\u20131702.","journal-title":"Cancer immunology research"},{"issue":"21","key":"1953_CR85","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.3390\/ijms252111384","volume":"25","author":"R. Masnikosa","year":"2024","unstructured":"Masnikosa, R., Cvetkovi\u0107, Z., & Piri\u0107, D. (2024). Tumor biology hides novel therapeutic approaches to diffuse large B-Cell lymphoma: A narrative review. International Journal Of Molecular Sciences, 25(21), 11384.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"9","key":"1953_CR86","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00262-025-04133-w","volume":"74","author":"M. K\u0142opotowska","year":"2025","unstructured":"K\u0142opotowska, M. (2025). GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis. Cancer Immunology Immunotherapy, 74(9), 280.","journal-title":"Cancer Immunology Immunotherapy"},{"issue":"10","key":"1953_CR87","doi-asserted-by":"publisher","first-page":"130683","DOI":"10.1016\/j.bbagen.2024.130683","volume":"1868","author":"J. Tan","year":"2024","unstructured":"Tan, J. (2024). Targeting SMYD2 promotes ferroptosis and impacts the progression of pancreatic cancer through the c-Myc\/NCOA4 axis-mediated ferritinophagy. Biochimica Et Biophysica Acta-General Subjects, 1868(10), 130683.","journal-title":"Biochimica Et Biophysica Acta-General Subjects"},{"issue":"10","key":"1953_CR88","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1002\/jcp.30346","volume":"236","author":"M. Shang","year":"2021","unstructured":"Shang, M. (2021). TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N\/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. Journal of Cellular Physiology, 236(10), 6868\u20136883.","journal-title":"Journal of Cellular Physiology"},{"issue":"24","key":"1953_CR89","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.3390\/cells11244127","volume":"11","author":"Y. Jin","year":"2022","unstructured":"Jin, Y. (2022). C-MYC inhibited ferroptosis and promoted immune evasion in ovarian cancer cells through NCOA4 mediated ferritin autophagy. Cells, 11(24), 4127.","journal-title":"Cells"},{"issue":"2","key":"1953_CR90","doi-asserted-by":"publisher","first-page":"169","DOI":"10.32604\/or.2023.027815","volume":"31","author":"Y. Jin","year":"2023","unstructured":"Jin, Y. (2023). LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells. Oncology Research, 31(2), 169.","journal-title":"Oncology Research"},{"key":"1953_CR91","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jare.2024.04.033","volume":"65","author":"Y. Wu","year":"2024","unstructured":"Wu, Y. (2024). Sodium citrate targeting Ca2+\/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer. Journal of Advanced Research, 65, 89\u2013104.","journal-title":"Journal of Advanced Research"},{"key":"1953_CR92","doi-asserted-by":"publisher","first-page":"155135","DOI":"10.1016\/j.phymed.2023.155135","volume":"122","author":"R. Yang","year":"2024","unstructured":"Yang, R. (2024). Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis. Phytomedicine, 122, 155135.","journal-title":"Phytomedicine"},{"key":"1953_CR93","doi-asserted-by":"publisher","first-page":"930958","DOI":"10.3389\/fphar.2022.930958","volume":"13","author":"Z. Xiu","year":"2022","unstructured":"Xiu, Z. (2022). Caryophyllene oxide induces ferritinophagy by regulating the NCOA4\/FTH1\/LC3 pathway in hepatocellular carcinoma. Frontiers In Pharmacology, 13, 930958.","journal-title":"Frontiers In Pharmacology"},{"key":"1953_CR94","doi-asserted-by":"publisher","first-page":"154671","DOI":"10.1016\/j.phymed.2023.154671","volume":"112","author":"Z. Zhu","year":"2023","unstructured":"Zhu, Z. (2023). A novel sesquiterpene lactone fraction from eupatorium Chinense L. suppresses hepatocellular carcinoma growth by triggering ferritinophagy and mitochondrial damage. Phytomedicine, 112, 154671.","journal-title":"Phytomedicine"},{"key":"1953_CR95","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.freeradbiomed.2024.07.002","volume":"222","author":"X. Zhu","year":"2024","unstructured":"Zhu, X. (2024). Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1\/mTORC1\/TFEB signaling axis. Free Radical Biology And Medicine, 222, 552\u2013568.","journal-title":"Free Radical Biology And Medicine"},{"issue":"7","key":"1953_CR96","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1158\/1078-0432.CCR-22-3179","volume":"29","author":"Y. Liu","year":"2023","unstructured":"Liu, Y. (2023). Protein kinase B (PKB\/AKT) protects IDH-mutated glioma from ferroptosis via Nrf2. Clinical Cancer Research, 29(7), 1305\u20131316.","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"1953_CR97","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1007\/s12011-023-03930-7","volume":"202","author":"C. Hacioglu","year":"2024","unstructured":"Hacioglu, C., & Tuncer, C. (2024). Boric acid increases susceptibility to chemotherapy by targeting the ferritinophagy signaling pathway in TMZ resistant glioblastoma cells. Biological Trace Element Research, 202(8), 3574\u20133587.","journal-title":"Biological Trace Element Research"},{"issue":"5","key":"1953_CR98","doi-asserted-by":"publisher","first-page":"104691","DOI":"10.1016\/j.jbc.2023.104691","volume":"299","author":"B. Chen","year":"2023","unstructured":"Chen, B. (2023). PTEN-induced kinase PINK1 supports colorectal cancer growth by regulating the labile iron pool. Journal Of Biological Chemistry, 299(5), 104691.","journal-title":"Journal Of Biological Chemistry"},{"key":"1953_CR99","doi-asserted-by":"publisher","first-page":"109196","DOI":"10.1016\/j.cbi.2020.109196","volume":"328","author":"Z. Xu","year":"2020","unstructured":"Xu, Z. (2020). The vicious cycle between ferritinophagy and ROS production triggered EMT Inhibition of gastric cancer cells was through p53\/AKT\/mTor pathway. Chemico-Biological Interactions, 328, 109196.","journal-title":"Chemico-Biological Interactions"},{"key":"1953_CR100","doi-asserted-by":"publisher","first-page":"3920664","DOI":"10.1155\/2022\/3920664","volume":"2022(1)","author":"D. Guan","year":"2022","unstructured":"Guan, D. (2022). Ferritinophagy-Mediated ferroptosis and activation of Keap1\/Nrf2\/HO\u20101 pathway were conducive to EMT Inhibition of gastric cancer cells in action of 2, 2\u2032\u2010Di\u2010pyridineketone hydrazone dithiocarbamate Butyric acid ester. Oxidative Medicine and Cellular Longevity, 2022(1), 3920664.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"1953_CR101","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s40001-024-01930-4","volume":"29","author":"Y. Chen","year":"2024","unstructured":"Chen, Y. (2024). Baicalin promotes the sensitivity of NSCLC to cisplatin by regulating ferritinophagy and macrophage immunity through the KEAP1-NRF2\/HO-1 pathway. European Journal of Medical Research, 29(1), 387.","journal-title":"European Journal of Medical Research"},{"issue":"8","key":"1953_CR102","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/pharmaceutics14081715","volume":"14","author":"R. Villalobos-Manzo","year":"2022","unstructured":"Villalobos-Manzo, R. (2022). Identification of transferrin receptor 1 (TfR1) overexpressed in lung cancer cells, and internalization of magnetic Au-CoFe2O4 core-shell nanoparticles functionalized with its ligand in a cellular model of small cell lung cancer (SCLC). Pharmaceutics, 14(8), 1715.","journal-title":"Pharmaceutics"},{"issue":"12","key":"1953_CR103","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.3390\/cancers12123609","volume":"12","author":"H. Robertson","year":"2020","unstructured":"Robertson, H., Dinkova-Kostova, A. T., & Hayes, J. D. J. C. (2020). NRF2 and the ambiguous consequences of its activation during initiation and the subsequent stages of tumourigenesis. Cancers (Basel), 12(12), 3609.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1953_CR104","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/antiox11020298","volume":"11","author":"H. C. Chen","year":"2022","unstructured":"Chen, H. C. (2022). Vulnerability of triple-negative breast cancer to saponin formosanin C-induced ferroptosis. Antioxidants (Basel), 11(2), 298.","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"1953_CR105","doi-asserted-by":"publisher","first-page":"e0243812","DOI":"10.1371\/journal.pone.0243812","volume":"15","author":"C. Xiao","year":"2020","unstructured":"Xiao, C. (2020). Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation. PLoS One, 15(12), e0243812.","journal-title":"PLoS One"},{"issue":"2","key":"1953_CR106","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"Z. Li","year":"2021","unstructured":"Li, Z. (2021). Artesunate synergizes with Sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacologica Sinica, 42(2), 301\u2013310.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"5","key":"1953_CR107","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-019-1564-7","volume":"10","author":"S. Sui","year":"2019","unstructured":"Sui, S. (2019). Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell Death & Disease, 10(5), 331.","journal-title":"Cell Death & Disease"},{"key":"1953_CR108","doi-asserted-by":"publisher","first-page":"820593","DOI":"10.3389\/fphar.2022.820593","volume":"13","author":"J. Yin","year":"2022","unstructured":"Yin, J. (2022). Tetrandrine citrate suppresses breast cancer via depletion of glutathione peroxidase 4 and activation of nuclear receptor coactivator 4-mediated ferritinophagy. Frontiers In Pharmacology, 13, 820593.","journal-title":"Frontiers In Pharmacology"},{"key":"1953_CR109","doi-asserted-by":"publisher","first-page":"116250","DOI":"10.1016\/j.ejmech.2024.116250","volume":"268","author":"L. Zhu","year":"2024","unstructured":"Zhu, L. (2024). Identification of a ferritinophagy inducer via Sinomenine modification for the treatment of colorectal cancer. European Journal Of Medicinal Chemistry, 268, 116250.","journal-title":"European Journal Of Medicinal Chemistry"},{"key":"1953_CR110","doi-asserted-by":"publisher","first-page":"1025067","DOI":"10.3389\/fonc.2022.1025067","volume":"12","author":"W. Li","year":"2022","unstructured":"Li, W. (2022). Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy. Frontiers In Oncology, 12, 1025067.","journal-title":"Frontiers In Oncology"},{"key":"1953_CR111","doi-asserted-by":"publisher","first-page":"1156062","DOI":"10.3389\/fmolb.2023.1156062","volume":"10","author":"H. Shi","year":"2023","unstructured":"Shi, H. (2023). Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis. Front Mol Biosci, 10, 1156062.","journal-title":"Front Mol Biosci"},{"issue":"12","key":"1953_CR112","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1080\/15548627.2021.1911016","volume":"17","author":"X. Qin","year":"2021","unstructured":"Qin, X. (2021). Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells. Autophagy, 17(12), 4266\u20134285.","journal-title":"Autophagy"},{"issue":"24","key":"1953_CR113","doi-asserted-by":"publisher","first-page":"2208063","DOI":"10.1002\/smll.202208063","volume":"19","author":"B. Liu","year":"2023","unstructured":"Liu, B. (2023). 2D MoS2 nanosheets induce ferroptosis by promoting NCOA4-dependent ferritinophagy and inhibiting Ferroportin. Small (Weinheim An Der Bergstrasse, Germany), 19(24), 2208063.","journal-title":"Small (Weinheim An Der Bergstrasse, Germany)"},{"key":"1953_CR114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10549-010-0849-4","volume":"126","author":"S. I. Shpyleva","year":"2011","unstructured":"Shpyleva, S. I. (2011). Role of ferritin alterations in human breast cancer cells. Breast Cancer Research And Treatment, 126, 63\u201371.","journal-title":"Breast Cancer Research And Treatment"},{"issue":"4","key":"1953_CR115","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/nar\/gkx1248","volume":"46","author":"J. J. Chan","year":"2018","unstructured":"Chan, J. J. (2018). A FTH1 gene: Pseudogene: MicroRNA network regulates tumorigenesis in prostate cancer. Nucleic Acids Research, 46(4), 1998\u20132011.","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"1953_CR116","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/cancers13040851","volume":"13","author":"S. Fathima","year":"2021","unstructured":"Fathima, S., Sinha, S., & Donakonda, S. J. C. (2021). Network analysis identifies drug targets and small molecules to modulate apoptosis resistant cancers. Cancers (Basel), 13(4), 851.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1953_CR117","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41420-020-00306-x","volume":"6","author":"Z. Liu","year":"2020","unstructured":"Liu, Z. (2020). Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5. Cell Death Discovery, 6(1), 72.","journal-title":"Cell Death Discovery"},{"issue":"1","key":"1953_CR118","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41420-023-01753-y","volume":"9","author":"J. Wang","year":"2023","unstructured":"Wang, J. (2023). Ferritinophagy: Research advance and clinical significance in cancers. Cell Death Discov, 9(1), 463.","journal-title":"Cell Death Discov"},{"issue":"6","key":"1953_CR119","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/md23060258","volume":"23","author":"Y. Wu","year":"2025","unstructured":"Wu, Y. (2025). Targeting ferroptosis in tumors: Novel Marine-Derived compounds as regulators of lipid peroxidation and GPX4 signaling. Marine Drugs, 23(6), 258.","journal-title":"Marine Drugs"},{"key":"1953_CR120","doi-asserted-by":"publisher","first-page":"104907","DOI":"10.1016\/j.critrevonc.2025.104907","volume":"214","author":"M. Ebrahimnezhad","year":"2025","unstructured":"Ebrahimnezhad, M., & Valizadeh, A. (2025). and B.J.C.R.i.O.H. Yousefi, Ferroptosis and Immunotherapy: Breaking Barriers in Cancer Treatment Resistance. Critical Reviews In Oncology Hematology, 214, 104907.","journal-title":"Critical Reviews In Oncology Hematology"},{"issue":"49","key":"1953_CR121","first-page":"56834","volume":"15","author":"Y. Bao","year":"2023","unstructured":"Bao, Y. (2023). Multifunctional tumor-targeting carbon Dots for tumor microenvironment activated ferroptosis and immunotherapy in cancer treatment. Acs Applied Materials & Interfaces, 15(49), 56834\u201356845.","journal-title":"Acs Applied Materials & Interfaces"},{"issue":"1","key":"1953_CR122","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y. Mou","year":"2019","unstructured":"Mou, Y. (2019). Ferroptosis, a new form of cell death: Opportunities and challenges in cancer. Journal Of Hematology & Oncology, 12(1), 34.","journal-title":"Journal Of Hematology & Oncology"},{"key":"1953_CR123","doi-asserted-by":"publisher","first-page":"1043344","DOI":"10.3389\/fphar.2022.1043344","volume":"13","author":"K. Sun","year":"2022","unstructured":"Sun, K. (2022). Ferritinophagy, a form of autophagic ferroptosis: New insights into cancer treatment. Frontiers in pharmacology, 13, 1043344.","journal-title":"Frontiers in pharmacology"},{"issue":"20","key":"1953_CR124","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.3390\/cancers15205043","volume":"15","author":"Y. Huang","year":"2023","unstructured":"Huang, Y. (2023). Photodynamic therapy combined with ferroptosis is a synergistic antitumor therapy strategy. Cancers, 15(20), 5043.","journal-title":"Cancers"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01953-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01953-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01953-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:02:52Z","timestamp":1772863372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01953-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1953"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01953-6","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"12 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}